Cost-effectiveness of tocilizumab in severe COVID-19: to see or not to see. Pischel L, Goshua G. Clin Infect Dis 2021 May 17. pii: 6277058. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pischel L, Goshua G. Cost-effectiveness of tocilizumab in severe COVID-19: to see or not to see. Clin Infect Dis 2021 May 17. pii: 6277058. doi: 10.1093.
PMID: 33999992